Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS

J Invasive Cardiol. 2003 Sep;15(9):536-53.

Authors

Dean J Kereiakes¹, James Tcheng, Edward T A Fry, Deepak L Bhatt, Gideon Bosker, Jose G Diez, James J Ferguson 3rd, Glenn N Levine, Gary L Schaer, James Zidar, CATH Clinical Consensus Panel

Affiliation

¹ The Lindner Center for Research and Education, Ohio State University, Cincinnati, USA.

PMID: 12947218

No abstract available

Publication types

Review

MeSH terms

Angina, Unstable / drug therapy
Angina, Unstable / therapy*
Angioplasty, Balloon, Coronary / methods*
Cardiac Catheterization / methods*
Clinical Trials as Topic
Economics, Pharmaceutical
Factor Xa Inhibitors
Hematologic Agents / economics
Hematologic Agents / therapeutic use*
Humans
Myocardial Infarction / drug therapy
Myocardial Infarction / therapy*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Practice Guidelines as Topic
Risk Assessment
Stents

Substances

Factor Xa Inhibitors
Hematologic Agents
Platelet Glycoprotein GPIIb-IIIa Complex